BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 19131854)

  • 1. Paraneoplastic neurological syndromes: a review.
    Toothaker TB; Rubin M
    Neurologist; 2009 Jan; 15(1):21-33. PubMed ID: 19131854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing paraneoplastic neurological disorders.
    de Beukelaar JW; Sillevis Smitt PA
    Oncologist; 2006 Mar; 11(3):292-305. PubMed ID: 16549814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic neurological syndromes.
    Honnorat J; Antoine JC
    Orphanet J Rare Dis; 2007 May; 2():22. PubMed ID: 17480225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and management of paraneoplastic neurological syndromes].
    Saji E; Kawachi I; Nishizawa M
    Brain Nerve; 2010 Apr; 62(4):319-30. PubMed ID: 20420171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurological syndromes, encephalitis].
    Yamamoto T; Tsuji S
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Paraneoplastic neurological syndromes in 2008].
    Honnorat J
    Rev Neurol (Paris); 2009 May; 165 Suppl 3():S59-65. PubMed ID: 19524096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological features of neurological paraneoplastic syndromes.
    Lorusso L; Hart IK; Giometto B; Pezzani R; Broome JC; Gritti D; Gasparetto C; Ricevuti G
    Int J Immunopathol Pharmacol; 2004; 17(2):135-44. PubMed ID: 15171814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Onconeural antibodies as a tool for diagnosis of malignant tumors and paraneoplastic neurological disorders].
    Belousov PV; Shebzukhov IuV; Nedospasov SA; Kuprash DV
    Mol Gen Mikrobiol Virusol; 2007; (2):6-13. PubMed ID: 17598451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Paraneoplastic neurological syndrome and autoantibodies].
    Hayashi Y; Inuzuka T
    Brain Nerve; 2013 Apr; 65(4):385-93. PubMed ID: 23568986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraneoplastic neurologic syndromes: approaches to diagnosis and treatment.
    Bataller L; Dalmau J
    Semin Neurol; 2003 Jun; 23(2):215-24. PubMed ID: 12894387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New concepts in paraneoplastic neurological syndromes.
    Honnorat J; Viaccoz A
    Rev Neurol (Paris); 2011 Oct; 167(10):729-36. PubMed ID: 21890156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Paraneoplastic neurological syndrome--definition and history].
    Inuzuka T
    Brain Nerve; 2010 Apr; 62(4):301-8. PubMed ID: 20420169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathogenesis of paraneoplastic neurological syndromes].
    Tanaka K
    Brain Nerve; 2010 Apr; 62(4):309-18. PubMed ID: 20420170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autonomic paraneoplastic neurological syndromes.
    Lorusso L; Hart IK; Ferrari D; Ngonga GK; Gasparetto C; Ricevuti G
    Autoimmun Rev; 2007 Jan; 6(3):162-8. PubMed ID: 17289552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on paraneoplastic neurological syndromes.
    Didelot A; Honnorat J
    Curr Opin Oncol; 2009 Nov; 21(6):566-72. PubMed ID: 19620862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraneoplastic neurological syndromes and onconeural antibodies: clinical and immunological aspects.
    Storstein A; Vedeler CA
    Adv Clin Chem; 2007; 44():143-85. PubMed ID: 17682342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers.
    Giometto B; Grisold W; Vitaliani R; Graus F; Honnorat J; Bertolini G;
    Arch Neurol; 2010 Mar; 67(3):330-5. PubMed ID: 20212230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on paraneoplastic and autoimmune disorders of the central nervous system.
    Rosenfeld MR; Dalmau J
    Semin Neurol; 2010 Jul; 30(3):320-31. PubMed ID: 20577938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer.
    Rojas-Marcos I; Rousseau A; Keime-Guibert F; Reñé R; Cartalat-Carel S; Delattre JY; Graus F
    Medicine (Baltimore); 2003 May; 82(3):216-23. PubMed ID: 12792307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
    Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
    J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.